secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2026-06-16T21:03:13+00:00
Accession:  0001493152-26-028912
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics announces proposed rights offering with exercise price floor of $1.25 per share
--------------------------------------------------------------------------------

- Each right entitles holder to buy one share at greater of $1.25/share or 20% above market on day before record date.
- Rights are transferable and intended to be listed on an exchange; 9-month exercise period.
- Upon exercise, holder receives a subsequent 9-month right at greater of $1.75/share or 40% above market.
- Record date set as 30th day after SEC declares registration statement effective; no assurance of completion.
- Conditions include SEC effectiveness, shareholder vote for share increase if needed, and board approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226028912/0001493152-26-028912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226028912/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer